XD4-27560-25548
3 vaccinations
1 coded response
31 check-ins
0 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 222 / VA
- Registered
- 2021-04-12
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-04-10
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-12
Registered in v-safe
-
2021-04-12
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-14
- 2021-04-15
-
2021-04-16
Health check-in — days 1–6 daily, dose 1Feeling: Good · Muscle or body aches, Abdominal painAdult check-in
- 2021-04-19
- 2021-04-24
- 2021-05-03
- 2021-05-10
- 2021-05-15
- 2021-05-24
- 2021-07-10
- 2021-10-09
-
2021-11-06
Dose 2 — Pfizer-BioNTech
- 2021-11-06
-
2021-11-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea, VomitingAdult check-in
- 2021-11-09
- 2021-11-10
- 2021-11-11
- 2021-11-13
- 2021-11-20
- 2021-11-27
- 2021-12-11
- 2021-12-20
- 2022-02-05
-
2022-10-11
Dose 3 — Pfizer-BioNTech
- 2022-10-16
- 2022-10-18
- 2022-10-25
- 2022-11-01
- 2022-11-10
- 2022-11-15
-
2023-01-12
Survey response — 3 months, dose 3MedDRA: COVID-19, Cholecystectomy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationMedDRA releases: 2024-11
-
2023-01-12
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2023-01-13
Call successfulDoes not wish to fill out VAERS report
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-10 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-06 | Pfizer-BioNTech | No |
| 3 | 2022-10-11 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-01-12 | Successful 2023-01-13 |
Does not wish to fill out VAERS report |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cholecystectomy | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release